Any feedback?
Literature summary for 3.4.21.68 extracted from
- Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial (2008), Clin. Trials, 5, 308-315.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | t-PA therapy has a clinically important and statistically significant benefit in spite of subgroup imbalances in baseline stroke severity and an increased risk of symptomatic intracerebral hemorrhage in patients receiving t-PA | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| t-PA | - |
Homo sapiens |
| Tissue plasminogen activator | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
